Biovie is trading 6.43% up at $1.49, versus its October 7 close of $1.40; no confirmed company announcement explains the October 8 pre-market rise.

  • BioVie’s investor-relations news page lists its latest release as September 8.
  • A September 26 notice advertised an October 8 investor webinar, but available sources do not establish that it caused the move.
  • Broader markets are also lower, so market direction does not clearly explain the gain.